Genome-wide linkage analysis of von Willebrand factor plasma levels: Results from the GAIT project

Thrombosis and Haemostasis

Volumn 89, Issue 3, 2003, Pages 468-474

  Souto, Juan Carlos ^a   Almasy, Laura ^b   Soria, Jose Manuel ^a   Buil, Alfonso ^a   Stone, William ^b   Lathrop, Mark ^c   Blangero, John ^b   Fontcuberta, Jordi ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

ABO blood group; Genome wide linkage analysis; Von Willebrand factor

Indexed keywords

DNA MARKER; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CHILD; CHROMOSOME 1; CHROMOSOME 12P; CHROMOSOME 19Q; CHROMOSOME 2; CHROMOSOME 22; CHROMOSOME 2Q; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 9Q; FEMALE; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; INFANT; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SPAIN; STRUCTURAL GENE; THROMBOPHILIA; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENOME, HUMAN; HUMANS; INFANT; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; RISK FACTORS; SPAIN; THROMBOPHILIA; VON WILLEBRAND FACTOR;

EID: 0037338824     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Ginsburg D, Handin RL, Bonthron DT, Donlon TA, Bruns GAP, Latt SA, Orkin SH. Human von Willebrand factor (vWF): Isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-6.
3. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
4. O'Donell J, Tuddenham EGD, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825-8.
5. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 1102-8.
6. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT Study. Am J Hum Genet 2000; 67: 1452-9.
7. Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001; 86: 144-8.
8. Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101: 1546-51.
9. O'Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11: 343-51.
10. O'Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41.
11. Souto JC Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, Mateo J, Madoz P, Stone W, Blangero J, Fontcuberta J. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-8.
12. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
13. Mohlke KL, Purkayastha AA, Westrick RJ, Smith PL, Petryniak B, Lowe JB, Ginsburg D. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered line-age-specific expression of a glycosyltransferase. Cell 1999; 96: 111-20.
14. Sodetz JM, Paulson JC, McKee PA, Carbohydrate composition and identification of blood group A, B and H oligossacharide structures of human factor VIII/von Willebrand factor. J Biol Chem 1979; 254: 10754-60.
15. Keightley AM, Lam YM, Brady JN, Cameron C, Lillicrap D. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: Identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93: 4277-83.
16. Harvey PJ, Keightley AM, Lam YM, Cameron C, Lillicrap D. A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 2000; 109: 349-3.
17. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man, I: Models and analytical methods. Ann Hum Genet 1986; 50: 81-94.
18. Almasy L, Hixson JE, Rainwater DL, Cole S, William JT, Mahaney C, Vanderberg JL, Stern MP, MacCluer JW, Blangero J. Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet 1999; 64: 1686-93.
19. Erketin-Taner N. Graff-Radford N, Younkin LH, Eckman Ch, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000; 290: 2303-2304.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
21. Dyke B. PEDSYS: A Pedigree Data Management System. User's Manual. PGL Tech Rep 2. Population Laboratory, Department of Gentics, Southwest Foundation for Biomedical Research, San Antonio, 1995.
22. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet 1999; 65: 531-44.
23. Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 2000; 19: S8-S14.
24. Almasy L, Blangero JC. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-211.
25. Self SG, Liang K-Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under non-standard conditions. J Am Stat Assoc 1987; 82: 605-10.
26. Boehnke M, Lange K. Ascertainment and goodness of fit of variance component models for pedigree data. Prog Clin Biol Res 1984; 147: 173-92.
27. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000; 355: 308-11.
28. Almasy L, MacCluer JW. Association studies of vascular phenotypes. How and why? Arterioscler Thromb Vasc Biol 2002; 22: 1055-7.
29. O'Donnel JS, Boulton FE, Manning RA, Laffan MA. Concordant FVIII:VWF ratio across ABO blood group genotypes suggests the effect of the ABO locus on plasma FVIII/VWF levels is mediated by rate of clearance. Thromb Haemost 2001; (Suppl); abstract P223.
30. Mancusso DJ, Tuley EA, Westfield LA, Lester-Mancusso TL, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: Structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-69.
31. Orstavik KH, Kornstad L, Reisner H, Berg K. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood 1989; 73: 990-3.
32. O'Donnel JS, Boulton FE, Manning RA, Laffan MA. Secretor blood group genotype does not influence plasma concentration of factor VII or von Willebrand factor. Thromb Haemost 2000 (Suppl); abstract P229.
33. Blangero B, Wiliams JT, Almasy L. Quantitative trait locus mapping using human pedigrees. Hum Biol 2000; 72: 35-62.
34. Sham PC, Cherny SS, Purcell S, Hewitt JK. Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 2000; 66: 1616-30.